News|Articles|October 28, 2025
Executive Summary: Charge Detection Mass Spectrometry (CDMS): From Complexity to Clarity – A New Era in Biomolecular Analysis
Author(s)Waters Corporation
Key Takeaways
CDMS is reshaping the characterization of complex biotherapeutics by enabling precise analysis of large, heterogeneous biomolecular complexes and gene therapy vectors. This article explores how CDMS enhances resolution in quality assessments across biotherapeutic development and structural biology research—surpassing the capabilities of conventional analytical techniques.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Thermo Fisher and NVIDIA Partner to Expand AI Driven Laboratory Automation
2
Rapid Native HIC–MS Using Ammonium Tartrate for Robust Drug-to-Antibody Ratio Characterization of Antibody–Drug Conjugates
3
Waters Corporation Shareholders Approve Share Issuance for Planned Combination with BD Biosciences and Diagnostics
4
Layer-Resolved Corneal Proteomics Enabled by Laser Ablation Sampling and LC–MS/MS
5